Allen T - Search Results

1

Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity.

Laginha K, Mumbengegwi D, Allen T. Laginha K, et al. Among authors: allen t. Biochim Biophys Acta. 2005 Jun 1;1711(1):25-32. doi: 10.1016/j.bbamem.2005.02.007. Epub 2005 Feb 24. Biochim Biophys Acta. 2005. PMID: 15904660 Free article.

2

Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.

Allen TM, Mumbengegwi DR, Charrois GJ. Allen TM, et al. Clin Cancer Res. 2005 May 1;11(9):3567-73. doi: 10.1158/1078-0432.CCR-04-2517. Clin Cancer Res. 2005. PMID: 15867261

3

Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer.

Laginha KM, Moase EH, Yu N, Huang A, Allen TM. Laginha KM, et al. Among authors: allen tm. J Drug Target. 2008 Aug;16(7):605-10. doi: 10.1080/10611860802229978. J Drug Target. 2008. PMID: 18686132

4

Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors.

Laginha KM, Verwoert S, Charrois GJ, Allen TM. Laginha KM, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6944-9. doi: 10.1158/1078-0432.CCR-05-0343. Clin Cancer Res. 2005. PMID: 16203786

5

Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer.

Allen TM, Cheng WW, Hare JI, Laginha KM. Allen TM, et al. Anticancer Agents Med Chem. 2006 Nov;6(6):513-23. doi: 10.2174/187152006778699121. Anticancer Agents Med Chem. 2006. PMID: 17100556 Review.

6

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells.

Ishida T, Kirchmeier MJ, Moase EH, Zalipsky S, Allen TM. Ishida T, et al. Among authors: allen tm. Biochim Biophys Acta. 2001 Dec 1;1515(2):144-58. doi: 10.1016/s0005-2736(01)00409-6. Biochim Biophys Acta. 2001. PMID: 11718670 Free article.

7

Expression and purification of two anti-CD19 single chain Fv fragments for targeting of liposomes to CD19-expressing cells.

Cheng WW, Das D, Suresh M, Allen TM. Cheng WW, et al. Among authors: allen tm. Biochim Biophys Acta. 2007 Jan;1768(1):21-9. doi: 10.1016/j.bbamem.2006.09.004. Epub 2006 Sep 19. Biochim Biophys Acta. 2007. PMID: 17046711 Free article.

8

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells.

Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S. Allen TM, et al. Biochim Biophys Acta. 1995 Jul 26;1237(2):99-108. doi: 10.1016/0005-2736(95)00085-h. Biochim Biophys Acta. 1995. PMID: 7632714 Free article.

9

In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach.

Iden DL, Allen TM. Iden DL, et al. Among authors: allen tm. Biochim Biophys Acta. 2001 Aug 6;1513(2):207-16. doi: 10.1016/s0005-2736(01)00357-1. Biochim Biophys Acta. 2001. PMID: 11470092 Free article.

10

Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.

Pastorino F, Mumbengegwi DR, Ribatti D, Ponzoni M, Allen TM. Pastorino F, et al. J Control Release. 2008 Feb 18;126(1):85-94. doi: 10.1016/j.jconrel.2007.11.010. Epub 2007 Nov 28. J Control Release. 2008. PMID: 18166243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,550 results

Search Page

Filters